IPCA Laboratories Ltd. | Ownership
Companies that own IPCA Laboratories Ltd.
DSP BlackRock Investment Managers Pvt Ltd.
7,085,291
5.61%
256,703
1.32%
07/31/2018
HDFC Asset Management Co. Ltd. (Invt Mgmt)
5,176,400
4.09%
0
0.28%
07/31/2018
ICICI Prudential Asset Management Co. Ltd.
4,100,679
3.25%
-404,307
0.26%
08/31/2018
UTI Asset Management Co. Ltd. (Investment Management)
2,702,905
2.14%
47,638
0.31%
08/31/2018
L&T Investment Management Ltd.
2,397,398
1.9%
381,479
0.5%
07/31/2018
Norges Bank Investment Management
2,360,353
1.87%
330,745
0%
03/31/2018
Goldman Sachs Asset Management International
2,087,632
1.65%
0
0.06%
06/30/2018
The Vanguard Group, Inc.
1,324,301
1.05%
-7,910
0%
07/31/2018
Aditya Birla Sun Life AMC Ltd.
1,244,000
0.99%
40,000
0.11%
07/31/2018
Franklin Templeton Asset Management (India) Pvt Ltd.
1,096,154
0.87%
-200,000
0.16%
07/31/2018
| Address |
142-AB, Kandivli Industrial Estate
Mumbai Maharashtra 400067
India
|
|
Employees
|
- |
| Website |
http://www.ipcalabs.com |
| Updated |
09/14/2018 |
| Ipca Laboratories Ltd. engages in the manufacture, research, and development of pharmaceutical products. It offers active pharmaceuical ingredients such as Atenolol, Chloroquine Phosphate, Furosemide, Hydroxychloroquine Sulphate, Metoprolol Succinate, Metoprolol Tartrate, and Pyrantel Salts. The company was founded on October 19, 1949 and is headquartered in Mumbai, India. |
